
Pembrolizumab-Induced Bullous Pemphigoid: Navigating Diagnostic Challenges and Treatment Resistance
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNZ185QnZLYzdMMktkY3E1UUZkT2JmNmtic1ZDZFN3ZFdVMmNMSVo3V0ptSmlzbXZ6WmtoSXR3V2k3cFZramktaGgtQjROcjBCT1p0NE5PT0xsNDJFb3ZjbThsUk1aT29nbGJvSm0wTEFwUlRFblVHa0hvXzVIazdQaEY0ZXpmaEpFVlQ0Rm82NXhUUG95TTlFc1RZbXVWYnFOaVZN?oc=5" target="_blank">Pembrolizumab-Induced Bullous Pemphigoid: Navigating Diagnostic Challenges and Treatment Resistance</a>&nbsp;&nbsp;<font color="#6f6f6f">Medscape</font>
